PMID: 25743822Mar 7, 2015Paper

Pemetrexed induces G1 phase arrest and apoptosis through inhibiting Akt activation in human non small lung cancer cell line A549

Asian Pacific Journal of Cancer Prevention : APJCP
Dong-Ming WuChun-Ting Wang

Abstract

Pemetrexed is an antifolate agent which has been used for treating malignant pleural mesothelioma and non small lung cancer in the clinic as a chemotherapeutic agent. In this study, pemetrexed inhibited cell growth and induced G1 phase arrest in the A549 cell line. To explore the molecular mechanisms of pemetrexed involved in cell growth, we used a two-dimensional polyacrylamide gel electrophoresis (2-DE) proteomics approach to analyze proteins changed in A549 cells treated with pemetrexed. As a result, twenty differentially expressed proteins were identified by ESI-Q-TOF MS/MS analysis in A549 cells incubated with pemetrexed compared with non-treated A549 cells. Three key proteins (GAPDH, HSPB1 and EIF4E) changed in pemetrexed treated A549 cells were validated by Western blotting. Accumulation of GAPDH and decrease of HSPB1 and EIF4E which induce apoptosis through inhibiting phosphorylation of Akt were noted. Expression of p-Akt in A549 cells treated with pemetrexed was reduced. Thus, pemetrexed induced apoptosis in A549 cells through inhibiting the Akt pathway.

References

Dec 6, 2000·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A A Adjei
May 13, 2003·The Journal of Biological Chemistry·Madhavi J RaneJon B Klein
Nov 5, 2003·Clinical Lung Cancer·Julian R Molina, Alex A Adjei
Mar 19, 2004·Nature·Hans-Guido WendelScott W Lowe
Apr 20, 2004·Oncogene·Arrigo De Benedetti, Jeremy R Graff
Jun 26, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alex A Adjei
Jul 1, 2005·The Journal of Pharmacology and Experimental Therapeutics·Haiqing DaiWilliam F Elmquist
Apr 8, 2009·Proceedings of the American Thoracic Society·Thomas E Stinchcombe, Mark A Socinski
Sep 2, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mark A SocinskiNick Thatcher
Sep 26, 2009·Cell Death and Differentiation·A ColellJ-E Ricci
Jun 19, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Ming-Fang WuJiunn-Liang Ko
Aug 24, 2010·Cellular Signalling·Carlos TristanAkira Sawa
Dec 17, 2010·Cancer Research·Scott B RothbartRichard G Moran
Feb 2, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard H de BoerJohan F Vansteenkiste
Feb 26, 2011·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayDonald Maxwell Parkin
Nov 8, 2011·Clinics in Chest Medicine·Scott Gettinger, Thomas Lynch
Dec 22, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E F SmitN Thatcher
Apr 28, 2012·Molecular Cancer·Aitziber BuquéGuillermo López-Vivanco
Jun 4, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Xin-Ju LiXin Jin
Apr 26, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Parisa KarimiMohammad R Nezami Ranjbar
Nov 26, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Xia LuoQing Guan
Nov 26, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Zhuang YuShi-Hai Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis